Activation of Akt characterizes estrogen receptor positive human breast cancers which respond to anthracyclines

por Yndestad, Synnøve, Austreid, Eilin, Svanberg, Ida R., Knappskog, Stian, Lønning, Per E., Eikesdal, Hans P.
Publicado 2017

High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function

por Yndestad, Synnøve, Austreid, Eilin, Knappskog, Stian, Chrisanthar, Ranjan, Lilleng, Peer Kåre, Lønning, Per Eystein, Eikesdal, Hans Petter
Publicado 2017

Impaired lymphatic function accelerates cancer growth

por Steinskog, Eli Sihn Samdal, Sagstad, Solfrid Johanne, Wagner, Marek, Karlsen, Tine Veronica, Yang, Ning, Markhus, Carl Erik, Yndestad, Synnøve, Wiig, Helge, Eikesdal, Hans Petter
Publicado 2016

Concomitant inactivation of the p53‐ and pRB‐ functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo

por Knappskog, Stian, Berge, Elisabet O., Chrisanthar, Ranjan, Geisler, Stephanie, Staalesen, Vidar, Leirvaag, Beryl, Yndestad, Synnøve, de Faveri, Elise, Karlsen, Bård O., Wedge, David C., Akslen, Lars A., Lilleng, Peer K., Løkkevik, Erik, Lundgren, Steinar, Østenstad, Bjørn, Risberg, Terje, Mjaaland, Ingvild, Aas, Turid, Lønning, Per E.
Publicado 2015